Season finale: Going the extra mile for patients with disabilities

To bring season 5 of the GOLD podcast to a close, join Jade as she sits down with Christy Seigel, General Manager, Breast and Women’s Cancers Portfolio, Novartis US Oncology, to discuss the importance of disability inclusion in the pharmaceutical industry.   In this episode, Jade and Christy unpick her transition from general medicine to women’s cancer, how companies can best extend oncology care to those with disabilities, ways to expand diversity, equity and inclusion schemes to better support those living with disabilities and more.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:    Going for gold in gynaecological cancers: https://www.emg-gold.com/post/going-for-gold-in-gynaecological-cancers  4 top tips to create the perfect ERG: https://www.emg-gold.com/post/4-top-tips-to-create-the-perfect-employee-resource-group  Translating policy into action: https://www.emg-gold.com/post/translating-policy-into-action  Last week’s episode: https://www.emg-gold.com/post/season-5-highlights-gold-medal-moments 

There are no comments yet.

Please log in to write the first comment.